🔗 Permalink

Inventor profile of:

Murat V. Kalayoglu

City:

Silver Spring, Maryland

Country:

United States

Published Applications:

Last publication date:

2024-10-17

Top Assignees for applications by Murat V. Kalayoglu

The entities that hold a legal rights for patent applications filed by inventor Kalayoglu Murat V.:

Topokine Therapeutics, Inc. 19 Newton, MA United States
Topokine Therapeutics, Inc. 14 Parsippany, NJ United States
Cartesian Therapeutics, Inc. 6 Gaithersburg, MD United States
Terakine Therapeutics, Inc. 1 Newton, MA United States
Cartesian Therapeutics, Inc. 1 Rockville, MD United States

Recent patent applications by Kalayoglu Murat V.

Murat V. Kalayoglu from Silver Spring, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-17

US20240344030A1

Chemistry; metallurgy

MULTIPROTEIN-ENGINEERED CELLS SECRETING A MULTISPECIFIC ANTIBODY

#2 | 2024-09-05

US20240294600A1

Chemistry; metallurgy

ANTI-BCMA CHIMERIC ANTIGEN RECEPTORS

#3 | 2024-04-18

US20240122943A1

Human necessities

METHODS AND COMPOSITIONS FOR REDUCING BODY FAT AND ADIPOCYTES

#4 | 2024-04-18

US20240122942A1

Human necessities

METHODS AND COMPOSITIONS FOR REDUCING BODY FAT AND ADIPOCYTES

#5 | 2023-10-19

US20230330105A1

Human necessities

METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT

#6 | 2023-06-08

US20230174944A1

Chemistry; metallurgy

ENGINEERED CELLS SECRETING THERAPEUTIC ENZYMES

#7 | 2022-05-19

US20220152206A1

Human necessities

COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT

#8 | 2022-03-24

US20220089678A1

Chemistry; metallurgy

Anti-BCMA chimeric antigen receptors

#9 | 2021-12-23

US20210393648A1

Human necessities

METHODS AND COMPOSITIONS FOR REDUCING BODY FAT AND ADIPOCYTES

#10 | 2021-10-07

US20210308143A1

Human necessities

COMPOSITIONS AND METHODS FOR REDUCING BODY FAT

#11 | 2021-07-22

US20210221868A1

Chemistry; metallurgy

Anti-BCMA chimeric antigen receptors

#12 | 2021-07-15

US20210213032A1

Human necessities

METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT

#13 | 2020-09-17

US20200291087A1

Chemistry; metallurgy

Anti-BCMA chimeric antigen receptors

#14 | 2020-09-10

US20200282059A1

Human necessities

COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT

#15 | 2020-03-05

US20200069699A1

Human necessities

COMPOSITIONS AND METHODS FOR REDUCING BODY FAT

#16 | 2019-01-31

US20190030073A1

Human necessities

CANCER IMMUNOTHERAPY WITH HIGHLY ENRICHED CD8+ CHIMERIC ANTIGEN RECEPTOR T CELLS

#17 | 2018-12-13

US20180353517A1

Human necessities

METHODS AND COMPOSITIONS FOR REDUCING BODY FAT AND ADIPOCYTES

#18 | 2018-07-19

US20180200372A1

Human necessities

Compositions and methods for topical delivery of prostaglandins to subcutaneous fat

#19 | 2018-06-21

US20180169111A1

Human necessities

Methods and compositions for topical delivery of prostaglandins to subcutaneous fat

#20 | 2018-04-19

US20180104255A1

Human necessities

Compositions and methods for reducing body fat

#21 | 2017-07-20

US20170202852A1

Human necessities

Topical dosage regimen

#22 | 2017-05-18

US20170136032A1

Human necessities

Methods and compositions for treating metabolic syndrome

#23 | 2016-12-08

US20160354386A1

Human necessities

Compositions and methods for reducing body fat

#24 | 2016-07-21

US20160206606A1

Human necessities

TOPICAL COMPOSITIONS COMPRISING A THIAZOLIDINEDIONE

#25 | 2016-03-10

US20160067263A1

Human necessities

Methods and compositions for topical delivery of prostaglandins to subcutaneous fat

#26 | 2016-02-25

US20160051562A1

Human necessities

Methods for reducing body fat using tafluprost and analogs thereof

#27 | 2015-12-17

US20150359801A1

Human necessities

Compositions and methods for reducing body fat

#28 | 2015-11-05

US20150313825A1

Human necessities

METHODS AND COMPOSITIONS FOR LOCALLY INCREASING BODY FAT

#29 | 2015-08-20

US20150231251A1

Human necessities

Methods for topical delivery of prostaglandins to subcutaneous fat

#30 | 2015-04-16

US20150105462A1

Human necessities

Compositions for topical delivery of prostaglandins to subcutaneous fat

#31 | 2015-01-22

US20150025151A1

Human necessities

Compositions and methods for reducing body fat

#32 | 2015-01-22

US20150025150A1

Human necessities

Methods for reducing body fat

#33 | 2014-11-27

US20140350104A1

Human necessities

Tafluprost and analogs thereof for reducing fat

#34 | 2014-10-02

US20140296299A1

Human necessities

Methods and compositions for locally increasing body fat

#35 | 2014-06-12

US20140163098A1

Human necessities

Compositions and methods for reducing body fat

#36 | 2014-05-22

US20140142075A1

Human necessities

Methods and compositions for locally increasing body fat

#37 | 2014-02-13

US20140045933A1

Chemistry; metallurgy

Methods and compositions for treating metabolic syndrome

#38 | 2013-07-11

US20130178525A1

Human necessities

Methods and compositions for reducing body fat and adipocytes

#39 | 2013-04-23

US13548482

Methods and compositions for reducing body fat and adipocytes

InventorID:

336072 ⎘